Standard Oxytocin Versus High Dose Oxytocin to Control Postpartum Hemorrhage in High Risk Pregnancy During Elective Cesarean Section

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-45
SponsorAin Shams University

About this trial

Controlling hemorrhage during and after a cesarean section reduces significantly maternal mortality and morbidity and the present study is important for detection of the effectiveness of routinely increasing the oxytocin dose instead of using the standard dose only in preventing postpartum hemorrhage and additional use of uterotonics in the first 24 hours after cesarean section for high risk pregnancy.

Eligibility criteria

Qualifiers

- Medical disorders ie: Hypertensive diseases with pregnancy - Diabetes Mellitus - Collagen diseases - Coagulopathies - Cardiac diseases - Anemia

History of postpartum hemorrhage

Placental disorders ie: placenta previa

Infertility and ICSI

Disqualifiers

- Oxytocin Allergy

Normal uncomplicated pregnancy

Emergency cesarean section

Exhausted uterus due to trial of normal labor

Trial design

Treatments tested in this trial

  • Oxytocin

Treatment groups

39 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators